Kai I. Cheang

1.2k total citations
36 papers, 908 citations indexed

About

Kai I. Cheang is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Obstetrics and Gynecology. According to data from OpenAlex, Kai I. Cheang has authored 36 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Reproductive Medicine, 13 papers in Public Health, Environmental and Occupational Health and 9 papers in Obstetrics and Gynecology. Recurrent topics in Kai I. Cheang's work include Ovarian function and disorders (15 papers), Reproductive Biology and Fertility (7 papers) and Gestational Diabetes Research and Management (6 papers). Kai I. Cheang is often cited by papers focused on Ovarian function and disorders (15 papers), Reproductive Biology and Fertility (7 papers) and Gestational Diabetes Research and Management (6 papers). Kai I. Cheang collaborates with scholars based in United States, Canada and Chile. Kai I. Cheang's co-authors include John E. Nestler, Paulina A. Essah, Edmond P. Wickham, Nicole W. Karjane, Jean‐Patrice Baillargeon, Susmeeta T. Sharma, Leila Z. Islam, Richard E. Ostlund, James R. Levy and M. Lynn Crismon and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Medicinal Chemistry and Fertility and Sterility.

In The Last Decade

Kai I. Cheang

34 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai I. Cheang United States 18 496 420 175 170 96 36 908
Mahnaz Bahri Khomami Australia 19 960 1.9× 699 1.7× 191 1.1× 131 0.8× 493 5.1× 49 1.6k
Chau Thien Tay Australia 20 1.1k 2.2× 725 1.7× 205 1.2× 50 0.3× 166 1.7× 69 1.4k
Angela Alamo Italy 15 259 0.5× 261 0.6× 149 0.9× 26 0.2× 16 0.2× 29 836
R. Heithecker Belgium 15 298 0.6× 573 1.4× 290 1.7× 42 0.2× 60 0.6× 16 822
Maria Clara Costa Calvo Venezuela 10 267 0.5× 195 0.5× 84 0.5× 49 0.3× 29 0.3× 21 633
Alessandra Bosetti Italy 17 77 0.2× 208 0.5× 162 0.9× 51 0.3× 10 0.1× 41 758
Abdul Hamid Zargar India 16 99 0.2× 82 0.2× 455 2.6× 48 0.3× 131 1.4× 63 905
Britt W. Jensen Denmark 13 20 0.0× 282 0.7× 101 0.6× 49 0.3× 31 0.3× 33 630
Ricardo Fernando Arrais Brazil 16 46 0.1× 140 0.3× 101 0.6× 17 0.1× 13 0.1× 41 537
Julia DiBello United States 13 27 0.1× 323 0.8× 101 0.6× 56 0.3× 16 0.2× 24 685

Countries citing papers authored by Kai I. Cheang

Since Specialization
Citations

This map shows the geographic impact of Kai I. Cheang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai I. Cheang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai I. Cheang more than expected).

Fields of papers citing papers by Kai I. Cheang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai I. Cheang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai I. Cheang. The network helps show where Kai I. Cheang may publish in the future.

Co-authorship network of co-authors of Kai I. Cheang

This figure shows the co-authorship network connecting the top 25 collaborators of Kai I. Cheang. A scholar is included among the top collaborators of Kai I. Cheang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai I. Cheang. Kai I. Cheang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McRae, MaryPeace, Teresa M. Salgado, Julie A. Patterson, et al.. (2019). Educational Outcomes Resulting From Restructuring a Scholarship Course for Doctor of Pharmacy Students. American Journal of Pharmaceutical Education. 83(8). 7246–7246. 3 indexed citations
2.
Pakyz, Amy, Kai I. Cheang, Jeremy S. Stultz, & Leticia R. Moczygemba. (2018). Learning Activities to Build Population Health Management Skills for Pharmacy Students. American Journal of Pharmaceutical Education. 82(8). 6390–6390. 1 indexed citations
3.
Essah, Paulina A., et al.. (2016). Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome. Journal of Women s Health. 25(6). 638–645. 17 indexed citations
4.
Brady, Megan, et al.. (2014). Sequential Compression Device Compliance in Postoperative Obstetrics and Gynecology Patients. Obstetrics and Gynecology. 125(1). 19–25. 28 indexed citations
5.
Nestler, John E., et al.. (2012). A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome.. PubMed. 123. 209–19; discussion 219. 15 indexed citations
6.
7.
Cheang, Kai I., Paulina A. Essah, Susmeeta T. Sharma, Edmond P. Wickham, & John E. Nestler. (2011). Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women. Fertility and Sterility. 96(2). 353–359.e1. 9 indexed citations
8.
Levy, James R., et al.. (2011). Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly. Metabolism. 61(3). 302–309. 39 indexed citations
9.
Cheang, Kai I.. (2009). Effect of Learner-Centered Teaching on Motivation and Learning Strategies in a Third-Year Pharmacotherapy Course. American Journal of Pharmaceutical Education. 73(3). 42–42. 1 indexed citations
10.
Cheang, Kai I.. (2009). Effect of Learner-Centered Teaching on Motivation and Learning Strategies in a Third-Year Pharmacotherapy Course. American Journal of Pharmaceutical Education. 73(3). 42–42. 52 indexed citations
11.
Cheang, Kai I.. (2009). INSTRUCTIONAL DESIGN AND ASSESSMENT Effect of Learner-Centered Teaching on Motivation and Learning Strategies in a Third-Year Pharmacotherapy Course. 2 indexed citations
12.
Cheang, Kai I., John E. Nestler, & Walter Futterweit. (2008). Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome. Endocrine Practice. 14(9). 1084–1094. 23 indexed citations
13.
Cheang, Kai I., Jean‐Patrice Baillargeon, Paulina A. Essah, et al.. (2008). Insulin-stimulated release of d-chiro-inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism. 57(10). 1390–1397. 108 indexed citations
14.
Cheang, Kai I., Carol A. Ott, Laura Hansen, et al.. (2008). Research in Women and Special Populations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(9). 1203–1203. 3 indexed citations
15.
Cheang, Kai I.. (2006). Cardiovascular Risk Reduction. The Consultant Pharmacist. 21(6). 493–499. 1 indexed citations
16.
Cheang, Kai I., Susmeeta T. Sharma, & John E. Nestler. (2006). Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?. Gynecological Endocrinology. 22(11). 595–604. 27 indexed citations
17.
Cheang, Kai I.. (2005). Multiple Cardiovascular Considerations in a 76-Year-Old Man. The Consultant Pharmacist. 20(6). 519–524. 1 indexed citations
18.
Terry, Christi M., et al.. (2004). Polymorphisms in the 5′‐UTR of the tissue factor gene are associated with altered expression in human endothelial cells. Journal of Thrombosis and Haemostasis. 2(8). 1351–1358. 12 indexed citations
19.
Cheang, Kai I., Paulina A. Essah, & John E. Nestler. (2004). A Paradox: The Roles of Inositolphosphoglycans in mediating insulin sensitivity and Hyperandrogenism in the Polycystic Ovary Syndrome. HORMONES. 3(4). 244–251. 2 indexed citations
20.
Munger, Mark & Kai I. Cheang. (2000). β‐Blocker Therapy: A Standard of Care for Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(11P2). 359S–367S. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahnaz Bahri Khomami Breakdown of academic impact, for papers by Chau Thien Tay Breakdown of academic impact, for papers by Angela Alamo Breakdown of academic impact, for papers by R. Heithecker Breakdown of academic impact, for papers by Maria Clara Costa Calvo Breakdown of academic impact, for papers by Alessandra Bosetti Breakdown of academic impact, for papers by Abdul Hamid Zargar Breakdown of academic impact, for papers by Britt W. Jensen Breakdown of academic impact, for papers by Ricardo Fernando Arrais Breakdown of academic impact, for papers by Julia DiBello
Rankless by CCL
2026